Evaluation of the Efficacy of a Probiotic Product as an Adjuvant Treatment for Vulvovaginal Candidiasis

Abroad (travel likely)Recruiting

Conditions

Vulvovaginal Candidiasis (VVC)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Hospital Universitario de Torrevieja, Torrevieja, Alicante, Spain

    Contact: Study coordinator (Ana María Navarro Fenoll) · navarro_anafen@gva.es · 608 33 07 27
    Contact: Study coordinator (Eduardo Cazorla Amorós) · cazorla_edu@gva.es
    Contact: Principal Investigator (Eduardo Cazorla Amorós, MD)
    Duska Beric, MD (Sub-investigator)
    Elisa Peñalver Escolano, MD (Sub-investigator)
    Ana María Navarro Fenoll, SN (Sub-investigator)